Advanced search
Publication Cover
Expert Review of Anticancer Therapy Volume 12, 2012 - Issue 6
Submit an article Journal homepage
116
Views
10
CrossRef citations to date
0
Altmetric
Theme: Kidney Cancer - Review

Selecting patients for cytoreductive nephrectomy in advanced renal cell carcinoma: who and when

Axel Bex The Netherlands Cancer Institute, Division of Surgical Oncology, Department of Urology, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. [email protected]; The Netherlands Cancer Institute, Division of Surgical Oncology, Department of Urology, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. [email protected]
&
Tom Powles Barts Cancer Institute, Experimental Cancer Medicine Centre, Queen Mary, University of London (QMUL), Mile End Road, London E1 4NS, UK; Barts Cancer Institute, Experimental Cancer Medicine Centre, Queen Mary, University of London (QMUL), Mile End Road, London E1 4NS, UK
Pages 787-797 | Published online: 10 Jan 2014

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Jamal Zekri, Lydia M Dreosti, Marwan Ghosn, Emad Hamada, Mohamed Jaloudi, Ola Khorshid & Blaha Larbaoui. (2015) Multidisciplinary management of clear-cell renal cell carcinoma in Africa and the Middle East: current practice and recommendations for improvement. Journal of Multidisciplinary Healthcare 8, pages 335-344.
Read now
Matteo Santoni, Michele De Tursi, Alessandra Felici, Giovanni Lo Re, Riccardo Ricotta, Enzo Maria Ruggeri, Roberto Sabbatini, Daniele Santini, Vanja Vaccaro & Michele Milella. (2013) Management of metastatic renal cell carcinoma patients with poor-risk features: current status and future perspectives. Expert Review of Anticancer Therapy 13:6, pages 697-709.
Read now

Articles from other publishers (8)

Lorenzo Marconi, Roderick de Bruijn, Erik van Werkhoven, Christian Beisland, Kate Fife, Axel Heidenreich, Anil Kapoor, Jose Karam, Caroline Kauffmann, Tobias Klatte, Boerje Ljungberg, Surena Matin, Daniel Sjoberg, Michael Staehler, Grant D. Stewart, Simon Tanguay, Robert Uzzo, Sarah Welsh, Lori Wood, Chris Wood & Axel Bex. (2018) External validation of a predictive model of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma. World Journal of Urology 36:12, pages 1973-1980.
Crossref
Sung Han Kim, Kyung-Chae Jeong, Jae Young Joung, Ho Kyung Seo, Kang Hyun Lee & Jinsoo Chung. (2018) Prognostic significance of nephrectomy in metastatic renal cell carcinoma treated with systemic cytokine or targeted therapy: A 16-year retrospective analysis. Scientific Reports 8:1.
Crossref
Axel Bex, Börje Ljungberg, Hein van Poppel & Thomas Powles. (2016) The Role of Cytoreductive Nephrectomy: European Association of Urology Recommendations in 2016. European Urology 70:6, pages 901-905.
Crossref
Benjamin L. Jackson, Sarah Fowler & Simon T. Williams. (2015) Perioperative outcomes of cytoreductive nephrectomy in the UK in 2012 . BJU International 116:6, pages 905-910.
Crossref
Allard Noe, Grant D. Stewart & Axel Bex. (2015) The role of cytoreductive surgery in the era of targeted agents. Current Opinion in Urology 25:5, pages 374-380.
Crossref
Romain Mathieu, Géraldine Pignot, Alexandre Ingles, Maxime Crepel, Pierre Bigot, Jean-Christophe Bernhard, Florence Joly, Laurent Guy, Alain Ravaud, Abdel Rahmene Azzouzi, Gwenaelle Gravis, Christine Chevreau, Laurent Zini, Hervé Lang, Christian Pfister, Eric Lechevallier, Pierre-Olivier Fais, Julien Berger, Bertrand Vayleux, Morgan Roupret, François Audenet, Aurelien Descazeaud, Jerome Rigaud, Jean-Pascal Machiels, Michael Staehler, Laurent Salomon, Jean-Marie Ferriere, Francois Kleinclauss, Karim Bensalah & Jean-Jacques Patard. (2015) Nephrectomy improves overall survival in patients with metastatic renal cell carcinoma in cases of favorable MSKCC or ECOG prognostic features. Urologic Oncology: Seminars and Original Investigations 33:8, pages 339.e9-339.e15.
Crossref
Javier Puente Vázquez, T. Alonso Gordoa, J. Moreno, L. Poma, E. Diaz Rubio, A. Gomez, J. Blazquez & J. L. Gonzalez Larriba. (2015) New Challenges in Kidney Cancer Management: Integration of Surgery and Novel Therapies. Current Treatment Options in Oncology 16:3.
Crossref
J. Huber, C. Groeben & M.P. Wirth. (2014) Entfernung des Primärtumors bei hämatogen metastasierter TumorerkrankungRemoval of the primary tumor in hematogenous metastatic tumor disease. Der Urologe 53:6, pages 840-846.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.